Evaluation of cardiovascular event rates with hormone therapy in healthy, early postmenopausal women - Results from 2 large clinical trials

被引:64
作者
Lobo, RA [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
关键词
D O I
10.1001/archinte.164.5.482
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:482 / 484
页数:3
相关论文
共 10 条
[1]  
ARCHER DF, 1994, OBSTET GYNECOL, V83, P686
[2]   Evidence from randomised trials on the long-term effects of hormone replacement therapy [J].
Beral, V ;
Banks, E ;
Reeves, G .
LANCET, 2002, 360 (9337) :942-944
[3]  
*BRIT HEART FDN HL, 2000, BRIT HEART FDN STAT
[4]   A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease [J].
Grodstein, F ;
Manson, JE ;
Colditz, GA ;
Willett, WC ;
Speizer, FE ;
Stampfer, MJ .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (12) :933-941
[5]   Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women [J].
Hulley, S ;
Grady, D ;
Bush, T ;
Furberg, C ;
Herrington, D ;
Riggs, B ;
Vittinghoff, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07) :605-613
[6]  
Kannel William B, 2002, J Gend Specif Med, V5, P27
[7]   Estrogen plus progestin and the risk of coronary heart disease [J].
Manson, JE ;
Hsia, J ;
Johnson, KC ;
Rossouw, JE ;
Assaf, AR ;
Lasser, NL ;
Trevisan, M ;
Black, HR ;
Heckbert, SR ;
Detrano, R ;
Strickland, OL ;
Wong, ND ;
Crouse, JR ;
Stein, E ;
Cushman, M ;
Alving, B ;
Rossouw, JE ;
Pottern, L ;
Ludlam, S ;
McGowan, JA ;
Prentice, R ;
Anderson, G ;
LaCroix, A ;
Patterson, R ;
McTiernan, A ;
Cochrane, B ;
Hunt, J ;
Tinker, L ;
Kooperberg, C ;
McIntosh, M ;
Wang, CY ;
Chen, C ;
Bowen, D ;
Kristal, A ;
Stanford, J ;
Urban, N ;
Weiss, N ;
White, E ;
Shumaker, S ;
Rautaharju, P ;
Prineas, R ;
Naughton, M ;
Stein, E ;
Laskarzewski, P ;
Cummings, S ;
Nevitt, M ;
Dockrell, M ;
Harnack, L ;
Cammarata, F ;
Lindenfelser, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06) :523-534
[8]   Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate [J].
Utian, WH ;
Shoupe, D ;
Bachmann, G ;
Pinkerton, JV ;
Pickar, JH .
FERTILITY AND STERILITY, 2001, 75 (06) :1065-1079
[9]  
*WRIT GROUP WOM HL, 2002, JAMA-J AM MED ASSOC, V28, P321
[10]   Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management [J].
Zanger, D ;
Yang, BK ;
Ardans, J ;
Waclawiw, MA ;
Csako, G ;
Wahl, LM ;
Cannon, RO .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (06) :1797-1802